// App-Quantinova.ai

: CAR-T CELL THERAPY BRIDGING TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION LED TO SUPERIOR SURVIVAL FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS OUT OF REMISSION

Researchers

Presenter

  • Jia Chen

Principal Investigators

  • Xiang Zhang

  • Yi Fan

  • Aining Sun

  • Huiying Qiu

  • Xiaowen Tang

  • Yue Han

  • Chengcheng Fu

  • Zhengming Jin

  • Suning Chen

  • Yang Xu

  • Depei Wu

Medical Centers

  • Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Hematocrit

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A